Rennova Health Inc (RNVA) 0.23 $RNVA
Rennova Health, Inc. Granted 180 Day Extension by Nasdaq
BusinessWire - Wed Sep 14, 7:30AM CDT
Rennova Health, Inc. (NASDAQ:RNVA), (NASDAQ:RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that on September 13, 2016, Nasdaq confirmed that the Company had been granted an extension of 180 days to comply with rule 5550(a)(2) ("the Rule"
, relating to the bid price of the Company's common stock not meeting the minimum $1.00 per share requirement for continued listing.
RNVA: 0.23 (-0.01), RNVAZ: 0.07 (unch)
Rennova Health Reports Second Quarter 2016 Financial Results
BusinessWire - Mon Aug 15, 7:30AM CDT
Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software ("Rennova" or the "Company", reports financial results for the three and six months ended June 30, 2016, and provides a business update.
RNVA: 0.23 (-0.01), RNVAZ: 0.07 (unch)
Earnings Season is Here and These 4 Companies Deserve Your Attention
PR Newswire - Thu Aug 11, 8:50AM CDT
TechStockInsider.com Briefing: Earnings season is in full swing and the markets are buzzing with excitement. Many public companies are seeing analyst beats on quarterly/annual revenue growth. Many companies are announcing record numbers and despite the previous concerns over Brexit, the U.S. economy seems to be in recovery mode after the latest jobs numbers were released earlier this month. Heading into the market open here are four stocks we are watching ahead of earnings and following milestone announcements:
BNSO: 1.56 (+0.02), RNVA: 0.23 (-0.01), IMNP: 0.27 (-0.02)
Rennova Health Signs Agreement with Academy Medical to Provide Laboratory Services to U.S. Federal Government Customers
BusinessWire - Thu Aug 11, 7:30AM CDT
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces the signing of a contract with Academy Medical, LLC, a Service-Disabled Veteran-Owned Small Business, to promote the sale of services to the United States federal government. Academy has substantial experience in establishing, operating and maintaining effective sales channels, contract vehicles and business protocols, with a principal focus on federal government customers of medical services and supplies.
RNVA: 0.23 (-0.01), RNVAZ: 0.07 (unch)
Rennova Health to Hold Second Quarter Financial Results Conference Call on August 15th
BusinessWire - Thu Aug 04, 3:05PM CDT
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, today announced that the Company will host a conference call and provide a business update on August 15, 2016 to discuss the financial results for the second quarter of 2016.
RNVA: 0.23 (-0.01), RNVAZ: 0.07 (unch)
Rennova Health, Inc. Complies with Nasdaq Rule 5550(b)
BusinessWire - Tue Jun 14, 7:30AM CDT
Rennova Health, Inc. (NASDAQ:RNVA), (NASDAQ:RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers announced today that on June 8, 2016, Nasdaq confirmed that the Company complies with Nasdaq Rule 5550(b)(3) due to the fact that the Company had net income from continuing operations in excess of $500,000 in two of the three most recently completed fiscal years. Nasdaq had previously written to the Company on April 26, 2016 stating that the Company did not comply with the minimum stockholders' equity requirement under Nasdaq Rule 5550(b)(1). However, after consultation with the Company, Nasdaq determined that the Company does comply with Listing Rules 5550(b) and this matter is now closed.
RNVA: 0.23 (-0.01)
Rennova Health to Present At The LD Micro Invitational Conference
ACCESSWIRE - Mon Jun 06, 7:30AM CDT
WEST PALM BEACH, FL / ACCESSWIRE / June 6, 2016 / Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, today announced that it will be presenting at the 6th annual LD Micro Invitational Conference on Tuesday, June 7th, 2016 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. Seamus Lagan, CEO of Rennova Health, Inc., will be giving the presentation and meeting with investors. The conference will be held at the Luxe Sunset Boulevard Hotel in Los Angeles from June 7-9, 2016.
RNVA: 0.23 (-0.01)
Rennova Health Adds Electronic Medication Administration Record to M2Select Electronic Health Record Product
BusinessWire - Fri Jun 03, 7:30AM CDT
Rennova Health Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW) announces that its wholly owned electronic health records software developer Medical Mime, Inc. has added electronic medication management software to its flagship M2Select electronic health record (EHR) product. Launched in the fourth quarter of 2015, M2Select is sold to substance abuse treatment and behavioral health providers.
RNVA: 0.23 (-0.01)
Rennova Health Reports First Quarter 2016 Financial Results
BusinessWire - Mon May 16, 6:30AM CDT
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software, reports financial results for the three months ended March 31, 2016, and provides a business update.
RNVA: 0.23 (-0.01)
Rennova Health to Hold First Quarter Financial Results Conference Call on May 16th
BusinessWire - Thu May 12, 7:30AM CDT
Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, today announced that the Company will host a conference call and provide a business update on May 16, 2016 to discuss the financial results for the first quarter of 2016.
RNVA: 0.23 (-0.01)
Rennova Health Enters into Preferred Provider Network Agreement with ACPN
BusinessWire - Wed Apr 20, 7:00AM CDT
Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that it has entered into a preferred provider network agreement with ACPN. Under the agreement, ACPN's more than 24 million members across the U.S. and more than 750,000 international members now will have access to Rennova's industry-leading and high-complexity diagnostic testing laboratories.
RNVA: 0.23 (-0.01)
Rennova Health Announces 2015 Financial Results
BusinessWire - Tue Apr 19, 7:30AM CDT
Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software, today announced financial results for the 12 months ended December 31, 2015, and provided a business update.
RNVA: 0.23 (-0.01)
Rennova Health Announces Formation of Scientific Advisory Committee
BusinessWire - Tue Feb 09, 4:32PM CST
Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW), which owns and operates a diverse family of healthcare companies, announces the formation of a Scientific Advisory Committee. The Committee, which was appointed by the Company's board of directors, is comprised of Chairman Thomas Mendolia, D.O., George Lundberg, M.D., Bernard Manz, Ph.D., Georg Manz, Paul Billings, M.D., Kamran Ajami, M.D., Christopher Mason, Ph.D. and Asad Zaidi.
RNVA: 0.23 (-0.01)
Rennova Health, Inc. Granted U.S. Trademark for StableSpot(R), a Laboratory Specimen Transport System
Marketwired - Thu Jan 28, 4:00PM CST
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW), which owns and operates a diverse family of healthcare companies, received a trademark from the United States Patent and Trademark Office for StableSpot(R), a clinical dry specimen transport kit for collection, stabilization, and transport of urine, serum, plasma, and blood. This innovative new approach will provide convenient sample collection for a patient, help protect the integrity of samples, cut down on packing and shipping concerns, and reduce total laboratory supply costs.
RNVA: 0.23 (-0.01)
Rennova Health to Present at Source Capital Group's 2016 "Disruptive Growth & Healthcare" Conference on February 11
Marketwired - Wed Jan 27, 4:00PM CST
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW) announced today that CEO Seamus Lagan will provide a company overview at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on February 11, 2016 in New York City at 9 a.m. Eastern Time.
RNVA: 0.23 (-0.01)
Georgia's Largest Public Health Agency Signs Deal With Clinlab for New Lab Information System
Marketwired - Tue Jan 26, 4:00PM CST
Clinlab, Inc., a subsidiary of Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW) that develops and markets laboratory information and automation systems, announced today it has entered into an agreement with the Fulton County Department of Health & Wellness to provide technology for faster, more efficient processing and reporting of lab tests.
RNVA: 0.23 (-0.01)
Slone Partners Places VP of Global Business Development at CollabRx
PRWeb - Tue Jan 26, 2:15AM CST
National recruitment firm Slone Partners is pleased to announce the placement of Adrienne Craig-Kennard, a life sciences executive with extensive international business development experience, as vice president of global business development and strategic alliances at CollabRx, a leading clinical-decision support company.
RNVA: 0.23 (-0.01)
CollabRx Announces Adrienne Craig-Kennard as Vice President of Global Business Development and Strategic Alliances
GlobeNewswire - Tue Jan 19, 6:00AM CST
CollabRx, Inc., a leading clinical decision support company and wholly owned subsidiary of Rennova Health, Inc. (NASDAQ:RNVA) today announced Adrienne Craig-Kennard will serve as Vice President of Global Business Development and Strategic Alliances.
RNVA: 0.23 (-0.01)
Novel, Dictation-Based Electronic Health Record Is First of Its Kind to Be Certified by Federal Agency
Marketwired - Mon Jan 11, 2:30PM CST
Medical Mime, an electronic health records company owned by Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW), announced today that its M2PRO product earned "Meaningful Use" Stage 2 certification as a "Complete Ambulatory EHR" from the Office of the National Coordinator for Health Information Technology (ONC). The designation means Medical Mime's program conforms to the standards and certification criteria adopted by the Secretary of Health and Human Services (HHS). The designation also means that Medical Mime's EHR is included on the Certified Health IT Product List (CHPL), known as "Chapel."
RNVA: 0.23 (-0.01)
Rennova Health, Inc. Issues Letter to Stockholders; Provides Business Update and Milestones for 2016
Marketwired - Thu Jan 07, 4:10PM CST
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW) today announced that it has issued a letter to its stockholders providing a business update and milestones for 2016. The text of the letter, which has been posted to the company's website, follows below.
RNVA: 0.23 (-0.01)
Rennova Health, Inc. Granted 180 Day Extension by Nasdaq
BusinessWire - Wed Sep 14, 7:30AM CDT
Rennova Health, Inc. (NASDAQ:RNVA), (NASDAQ:RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that on September 13, 2016, Nasdaq confirmed that the Company had been granted an extension of 180 days to comply with rule 5550(a)(2) ("the Rule"
, relating to the bid price of the Company's common stock not meeting the minimum $1.00 per share requirement for continued listing. RNVA: 0.23 (-0.01), RNVAZ: 0.07 (unch)
Rennova Health Reports Second Quarter 2016 Financial Results
BusinessWire - Mon Aug 15, 7:30AM CDT
Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software ("Rennova" or the "Company"
, reports financial results for the three and six months ended June 30, 2016, and provides a business update. RNVA: 0.23 (-0.01), RNVAZ: 0.07 (unch)
Earnings Season is Here and These 4 Companies Deserve Your Attention
PR Newswire - Thu Aug 11, 8:50AM CDT
TechStockInsider.com Briefing: Earnings season is in full swing and the markets are buzzing with excitement. Many public companies are seeing analyst beats on quarterly/annual revenue growth. Many companies are announcing record numbers and despite the previous concerns over Brexit, the U.S. economy seems to be in recovery mode after the latest jobs numbers were released earlier this month. Heading into the market open here are four stocks we are watching ahead of earnings and following milestone announcements:
BNSO: 1.56 (+0.02), RNVA: 0.23 (-0.01), IMNP: 0.27 (-0.02)
Rennova Health Signs Agreement with Academy Medical to Provide Laboratory Services to U.S. Federal Government Customers
BusinessWire - Thu Aug 11, 7:30AM CDT
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces the signing of a contract with Academy Medical, LLC, a Service-Disabled Veteran-Owned Small Business, to promote the sale of services to the United States federal government. Academy has substantial experience in establishing, operating and maintaining effective sales channels, contract vehicles and business protocols, with a principal focus on federal government customers of medical services and supplies.
RNVA: 0.23 (-0.01), RNVAZ: 0.07 (unch)
Rennova Health to Hold Second Quarter Financial Results Conference Call on August 15th
BusinessWire - Thu Aug 04, 3:05PM CDT
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, today announced that the Company will host a conference call and provide a business update on August 15, 2016 to discuss the financial results for the second quarter of 2016.
RNVA: 0.23 (-0.01), RNVAZ: 0.07 (unch)
Rennova Health, Inc. Complies with Nasdaq Rule 5550(b)
BusinessWire - Tue Jun 14, 7:30AM CDT
Rennova Health, Inc. (NASDAQ:RNVA), (NASDAQ:RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers announced today that on June 8, 2016, Nasdaq confirmed that the Company complies with Nasdaq Rule 5550(b)(3) due to the fact that the Company had net income from continuing operations in excess of $500,000 in two of the three most recently completed fiscal years. Nasdaq had previously written to the Company on April 26, 2016 stating that the Company did not comply with the minimum stockholders' equity requirement under Nasdaq Rule 5550(b)(1). However, after consultation with the Company, Nasdaq determined that the Company does comply with Listing Rules 5550(b) and this matter is now closed.
RNVA: 0.23 (-0.01)
Rennova Health to Present At The LD Micro Invitational Conference
ACCESSWIRE - Mon Jun 06, 7:30AM CDT
WEST PALM BEACH, FL / ACCESSWIRE / June 6, 2016 / Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, today announced that it will be presenting at the 6th annual LD Micro Invitational Conference on Tuesday, June 7th, 2016 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. Seamus Lagan, CEO of Rennova Health, Inc., will be giving the presentation and meeting with investors. The conference will be held at the Luxe Sunset Boulevard Hotel in Los Angeles from June 7-9, 2016.
RNVA: 0.23 (-0.01)
Rennova Health Adds Electronic Medication Administration Record to M2Select Electronic Health Record Product
BusinessWire - Fri Jun 03, 7:30AM CDT
Rennova Health Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW) announces that its wholly owned electronic health records software developer Medical Mime, Inc. has added electronic medication management software to its flagship M2Select electronic health record (EHR) product. Launched in the fourth quarter of 2015, M2Select is sold to substance abuse treatment and behavioral health providers.
RNVA: 0.23 (-0.01)
Rennova Health Reports First Quarter 2016 Financial Results
BusinessWire - Mon May 16, 6:30AM CDT
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software, reports financial results for the three months ended March 31, 2016, and provides a business update.
RNVA: 0.23 (-0.01)
Rennova Health to Hold First Quarter Financial Results Conference Call on May 16th
BusinessWire - Thu May 12, 7:30AM CDT
Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, today announced that the Company will host a conference call and provide a business update on May 16, 2016 to discuss the financial results for the first quarter of 2016.
RNVA: 0.23 (-0.01)
Rennova Health Enters into Preferred Provider Network Agreement with ACPN
BusinessWire - Wed Apr 20, 7:00AM CDT
Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that it has entered into a preferred provider network agreement with ACPN. Under the agreement, ACPN's more than 24 million members across the U.S. and more than 750,000 international members now will have access to Rennova's industry-leading and high-complexity diagnostic testing laboratories.
RNVA: 0.23 (-0.01)
Rennova Health Announces 2015 Financial Results
BusinessWire - Tue Apr 19, 7:30AM CDT
Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software, today announced financial results for the 12 months ended December 31, 2015, and provided a business update.
RNVA: 0.23 (-0.01)
Rennova Health Announces Formation of Scientific Advisory Committee
BusinessWire - Tue Feb 09, 4:32PM CST
Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW), which owns and operates a diverse family of healthcare companies, announces the formation of a Scientific Advisory Committee. The Committee, which was appointed by the Company's board of directors, is comprised of Chairman Thomas Mendolia, D.O., George Lundberg, M.D., Bernard Manz, Ph.D., Georg Manz, Paul Billings, M.D., Kamran Ajami, M.D., Christopher Mason, Ph.D. and Asad Zaidi.
RNVA: 0.23 (-0.01)
Rennova Health, Inc. Granted U.S. Trademark for StableSpot(R), a Laboratory Specimen Transport System
Marketwired - Thu Jan 28, 4:00PM CST
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW), which owns and operates a diverse family of healthcare companies, received a trademark from the United States Patent and Trademark Office for StableSpot(R), a clinical dry specimen transport kit for collection, stabilization, and transport of urine, serum, plasma, and blood. This innovative new approach will provide convenient sample collection for a patient, help protect the integrity of samples, cut down on packing and shipping concerns, and reduce total laboratory supply costs.
RNVA: 0.23 (-0.01)
Rennova Health to Present at Source Capital Group's 2016 "Disruptive Growth & Healthcare" Conference on February 11
Marketwired - Wed Jan 27, 4:00PM CST
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW) announced today that CEO Seamus Lagan will provide a company overview at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on February 11, 2016 in New York City at 9 a.m. Eastern Time.
RNVA: 0.23 (-0.01)
Georgia's Largest Public Health Agency Signs Deal With Clinlab for New Lab Information System
Marketwired - Tue Jan 26, 4:00PM CST
Clinlab, Inc., a subsidiary of Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW) that develops and markets laboratory information and automation systems, announced today it has entered into an agreement with the Fulton County Department of Health & Wellness to provide technology for faster, more efficient processing and reporting of lab tests.
RNVA: 0.23 (-0.01)
Slone Partners Places VP of Global Business Development at CollabRx
PRWeb - Tue Jan 26, 2:15AM CST
National recruitment firm Slone Partners is pleased to announce the placement of Adrienne Craig-Kennard, a life sciences executive with extensive international business development experience, as vice president of global business development and strategic alliances at CollabRx, a leading clinical-decision support company.
RNVA: 0.23 (-0.01)
CollabRx Announces Adrienne Craig-Kennard as Vice President of Global Business Development and Strategic Alliances
GlobeNewswire - Tue Jan 19, 6:00AM CST
CollabRx, Inc., a leading clinical decision support company and wholly owned subsidiary of Rennova Health, Inc. (NASDAQ:RNVA) today announced Adrienne Craig-Kennard will serve as Vice President of Global Business Development and Strategic Alliances.
RNVA: 0.23 (-0.01)
Novel, Dictation-Based Electronic Health Record Is First of Its Kind to Be Certified by Federal Agency
Marketwired - Mon Jan 11, 2:30PM CST
Medical Mime, an electronic health records company owned by Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW), announced today that its M2PRO product earned "Meaningful Use" Stage 2 certification as a "Complete Ambulatory EHR" from the Office of the National Coordinator for Health Information Technology (ONC). The designation means Medical Mime's program conforms to the standards and certification criteria adopted by the Secretary of Health and Human Services (HHS). The designation also means that Medical Mime's EHR is included on the Certified Health IT Product List (CHPL), known as "Chapel."
RNVA: 0.23 (-0.01)
Rennova Health, Inc. Issues Letter to Stockholders; Provides Business Update and Milestones for 2016
Marketwired - Thu Jan 07, 4:10PM CST
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW) today announced that it has issued a letter to its stockholders providing a business update and milestones for 2016. The text of the letter, which has been posted to the company's website, follows below.
RNVA: 0.23 (-0.01)
